The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Laura Sutcliffe's Stock Ratings
UBS Analyst
Laura Sutcliffe is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/27/2025
Overall Average Return
-0.60%
Smart Score
Overall Average Return Percentile
39th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/24/2025 | RMD | Buy Now | ResMed | $237.87 | 19.82% | Laura Sutcliffe49% | $290 → $285 | Maintains | Buy | Get Alert |
| 01/27/2025 | TLX | Buy Now | Telix Pharmaceuticals | $18.82 | 16.9% | Laura Sutcliffe49% | $21 → $22 | Maintains | Buy | Get Alert |
| 11/15/2024 | TLX | Buy Now | Telix Pharmaceuticals | $18.82 | 11.58% | Laura Sutcliffe49% | → $21 | Initiates | → Buy | Get Alert |
| 08/23/2021 | UCBJY | Buy Now | UCB | $86.43 | — | Laura Sutcliffe49% | — | Upgrade | Neutral → Buy | Get Alert |
| 06/18/2021 | ARGX | Buy Now | argenx | $614.76 | -36.56% | Laura Sutcliffe49% | → $390 | Initiates | → Buy | Get Alert |
| 03/01/2021 | GNHAF | Buy Now | Vifor Pharma AG | — | — | Laura Sutcliffe49% | — | Upgrade | Sell → Neutral | Get Alert |
| 12/20/2019 | GLPG | Buy Now | Galapagos | $26.86 | — | Laura Sutcliffe49% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/31/2019 | GLPG | Buy Now | Galapagos | $26.86 | — | Laura Sutcliffe49% | — | Upgrade | Neutral → Buy | Get Alert |
